LGR5 and colorectal carcinoma: Two simultaneous studies using CRISPR-Cas9 to label (with GFP) and then eliminate LGR5+ CSC (by means of knock-in Caspase 9 or diphtheria toxin receptor cassettes) smartly demonstrated the plasticity of human and mouse CRC CSC [64,65].